Financing ·
IperionX Limited priced an underwritten U.S. public offering of 2,275,000 ADSs at US$21.98 per ADS on July 7, 2026…
IPXIPERIONX Ltd
IperionX Limited priced an underwritten U.S. public offering of 2,275,000 ADSs at US$21.98 per ADS on July 7, 2026, generating approximately US$50 million in gross proceeds to fund titanium manufacturing scale-up and the Atlas-Titan critical minerals project. The company also completed the acquisition of adjacent Atlas assets for US$3 million on July 1, 2026, adding high-grade stockpiles and infrastructure to its Titan Definitive Feasibility Study platform. During the quarter ended June 30, 2026, IperionX held US$35.2 million in cash and received a US$2.4 million reimbursement under the DPA Title III program immediately after quarter-end. Operations continued on a 24/7 schedule with temporary furnace downtime resolved without impacting downstream supply, while the company targets a 200 tpa production run-rate by end of 2026. IperionX operates in the critical minerals and titanium metal manufacturing industry, producing domestic titanium powder and components for defense, aerospace, and industrial applications.